PHAGELUX ANNOUNCES PRESENTATION AND INFRASTRUCTURE UPDATES
* : * : admin * : 2016-01-07 * : 118
SHANGHAI, MONTREAL and SALT LAKE CITY, Jan. 7, 2016Phagelux also announced today that it continues to improve the infrastructure necessary to support the scientific and sales endeavors of the company. According to Mr. Engel, recent improvements include the opening of a new pilot manufacturing facility in Suzhou China in January 2016, the upcoming expansion of the main China lab in Nanjing China, and the scheduled opening of a new 15,000 SF dedicated lysin development facility in Wuhan China in February 2016.
Phagelux, Inc., which utilizes bacteriophages, lysins and related technologies to create solutions for bacterial problems including adjuncts and alternatives to antibiotics, announced today that Mark Engel, Chief Executive Offer, will present a corporate overview at the 8th Annual Biotech Showcase Conference in San Francisco on Wednesday January 13, 2016 at 2:45 pm PST. Mr. Engel will outline the lead programs of the company.
previous item: PHAGELUX ANNOUNCES ACQUISITION OF OMNILYTICS next item: PHAGELUX ANNOUNCES EXPANSION CAPITAL AND OTHER UPDATES